CBOE vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
CBOE
CME
Investment Advisor Scores
CME
Nov 12, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | CBOE | CME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 28.7356 | 23.5294 | CME |
| PEG Ratio | 3.1218 | 4.1991 | CBOE |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 19.0% | 13.0% | CBOE |
| Earnings Growth | 43.2% | 16.1% | CBOE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.6/100 | 43.7/100 | CME |
| Profit Margin | 28.1% | 63.5% | CME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CBOE
MarkupPrice above SMA50, rising 50-day trend (5.7% over 20 days), RSI 74
CME
MarkupPrice above SMA50, rising 50-day trend (4.4% over 20 days), RSI 71
Fundamentals Snapshot
| Metric | CBOE | CME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.9 | 23.9 |
| Trailing P/E | 26.0 | 25.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.5% | 1.0% |
| Operating Margin | 0.4% | 0.7% |
| EPS | 14.05 | 12.38 |
| Dividend Yield | 0.01% | 0.02% |